Héloise Bourien

4PUBLICATIONS
41CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 03, 2026
Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors.

Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé

|Apr 08, 2024
Management of biliary tract cancers in early-onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort.

Antoine Lebeaud, Leony Antoun, Jane-Rose Paccard

|Sep 09, 2023
Locoregional Treatment in Intrahepatic Cholangiocarcinoma: Which Treatment for Which Patient?

Héloïse Bourien, Chiara Carlotta Pircher, Boris Guiu

|May 24, 2021
Impact of EPclin on adjuvant therapeutic decision making and comparison of EPclin to the PREDICT tool.

Héloïse Bourien, Véronique Quillien, Florence Godey

Pageof 1